ストックスクリーナーアプリを入手
641.35
0.65%
-4.20
プレマーケット:
655.94
14.59
+2.27%
前日終値:
$645.55
開ける：
$639.33
24時間の取引高:
395.64K
Relative Volume:
0.68
時価総額：
$51.31B
収益：
$4.04B
当期純損益:
$985.66M
株価収益率:
53.40
EPS:
12.01
ネットキャッシュフロー:
$774.34M
1週間 パフォーマンス:
+0.55%
1か月 パフォーマンス:
+13.48%
6か月 パフォーマンス:
+39.47%
1年 パフォーマンス:
+31.39%
1日の値動き範囲:
$636.00
$644.13
1週間の範囲:
$632.57
$648.55
52週間の値動き範囲:
$356.14
$688.12
Idexx Laboratories Inc Stock (IDXX) Company Profile
名前
Idexx Laboratories Inc
セクター
電話
(207) 556-0300
住所
ONE IDEXX DRIVE, WESTBROOK, ME
IDXX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
641.35 | 51.03B | 4.04B | 985.66M | 774.34M | 12.01 |
|
TMO
Thermo Fisher Scientific Inc
|
490.63 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
207.72 | 149.66B | 24.01B | 3.41B | 4.86B | 4.70 |
|
A
Agilent Technologies Inc
|
119.12 | 33.56B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
187.98 | 32.73B | 15.70B | 1.24B | 2.01B | 6.91 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-05 | 繰り返されました | BTIG Research | Buy |
| 2025-07-01 | 開始されました | Jefferies | Buy |
| 2024-12-02 | 開始されました | Leerink Partners | Outperform |
| 2024-07-25 | 開始されました | BTIG Research | Buy |
| 2024-01-30 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | 開始されました | Exane BNP Paribas | Outperform |
| 2023-12-04 | アップグレード | Cleveland Research | Neutral → Buy |
| 2023-08-02 | ダウングレード | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | ダウングレード | Stifel | Buy → Hold |
| 2022-07-21 | アップグレード | Goldman | Neutral → Buy |
| 2022-07-12 | 開始されました | Piper Sandler | Overweight |
| 2022-05-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-02-08 | 開始されました | Atlantic Equities | Overweight |
| 2021-11-18 | 開始されました | Morgan Stanley | Overweight |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-12 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-02-17 | 開始されました | Barclays | Overweight |
| 2019-09-09 | 開始されました | Goldman | Neutral |
| 2019-05-23 | 開始されました | Guggenheim | Buy |
| 2018-11-02 | 繰り返されました | BofA/Merrill | Buy |
| 2018-05-07 | 繰り返されました | Stifel | Buy |
| 2018-01-16 | 開始されました | Piper Jaffray | Overweight |
| 2017-08-23 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | アップグレード | CL King | Neutral → Buy |
| 2017-02-03 | ダウングレード | Feltl & Co. | Hold → Sell |
| 2016-09-29 | 再開されました | BofA/Merrill | Neutral |
| 2016-08-16 | 繰り返されました | Stifel | Buy |
| 2016-08-03 | アップグレード | Northcoast | Sell → Neutral |
| 2016-07-20 | 繰り返されました | Canaccord Genuity | Buy |
| 2016-04-19 | 繰り返されました | Canaccord Genuity | Buy |
| 2016-04-01 | 開始されました | CL King | Neutral |
| 2016-03-21 | 繰り返されました | Stifel | Buy |
| 2016-02-04 | 開始されました | Credit Suisse | Outperform |
| 2015-10-29 | 繰り返されました | Stifel | Buy |
| 2015-08-28 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | 繰り返されました | Stifel | Buy |
| 2015-07-23 | 繰り返されました | Canaccord Genuity | Buy |
すべてを表示
Idexx Laboratories Inc (IDXX) 最新ニュース
Is IDEXX Laboratories Inc. Forming a Bottom PatternWeekly Risk Summary & Community Supported Trade Ideas - mustnews.co.kr
Idexx Labs Surges to Top 500 Volume Despite 0.18% Slide as Analysts Back Buy Ratings - AInvest
Watch for Bullish Crossover in IDEXX Laboratories Inc.July 2025 Movers & Fast Moving Market Watchlists - beatles.ru
National Veterinary Associates Welcomes Brian McKeon to Board of Directors - The Malaysian Reserve
Live Chart Scan Detects Wedge Pattern in IDEXX Laboratories Inc.2025 Buyback Activity & AI Based Trade Execution Alerts - newsyoung.net
IDEXX Laboratories (NASDAQ:IDXX) Stock Price Expected to Rise, Morgan Stanley Analyst Says - MarketBeat
Published on: 2025-08-17 06:07:39 - beatles.ru
Earnings Not Telling The Story For IDEXX Laboratories, Inc. (NASDAQ:IDXX) After Shares Rise 25% - simplywall.st
Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX) and Aardvark Therapeutics, Inc. (AARD) - The Globe and Mail
Why IDEXX Laboratories Inc. stock attracts strong analyst attentionJuly 2025 WrapUp & Daily Risk Controlled Trade Plans - thegnnews.com
How IDEXX Laboratories Inc. stock performs during market volatilityJuly 2025 Retail & Verified Momentum Stock Ideas - sundaytimes.kr
IDEXX Laboratories: A Powerhouse in Veterinary Diagnostics with Strong Q2 2025 Outperformance and Strategic Innovation - AInvest
IDEXX Laboratories 2025 Investor Day: Jay Mazelsky Presentation - AInvest
Transcript : IDEXX Laboratories, Inc.Analyst/Investor Day - MarketScreener
A Quick Look at Today's Ratings for IDEXX Laboratories Inc(IDXX.US), With a Forecast Between $745 to $785 - 富途牛牛
IDEXX Laboratories: Morgan Stanley raises PT to $765, maintains Overweight rating. - AInvest
Idexx Laboratories Inc Insider Sold Shares Worth $263,814, According to a Recent SEC Filing - MarketScreener
Is IDEXX Laboratories Inc. forming a double bottomJuly 2025 Patterns & Real-Time Stock Movement Alerts - thegnnews.com
Insider Sell: Michael Erickson Sells Shares of IDEXX Laboratories Inc (IDXX) - GuruFocus
IDEXX Laboratories Executive Vice President Erickson Sells Shares on August 12, 2025. - AInvest
IDEXX Laboratories : Investor Day 2025 presentation - MarketScreener
There's Reason For Concern Over IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Massive 26% Price Jump - 富途牛牛
IDEXX Laboratories Executive Vice President Hunts Nimrata sells 1200 shares. - AInvest
Idexx Labs executive Hunt sells $787k in shares - Investing.com
Idexx Labs executive Hunt sells $787k in shares By Investing.com - Investing.com Canada
Piper Sandler Raises IDEXX Laboratories (IDXX) PT to $700, Cites Strong Q2 Results - Yahoo Finance
IDEXX Laboratories EVP buys, sells shares in single day. - AInvest
IDEXX Laboratories' 15min chart shows MACD, KDJ death crosses. - AInvest
Here's How Much a $1000 Investment in Idexx Laboratories Made 10 Years Ago Would Be Worth Today - Yahoo Finance
A Closer Look at IDEXX Laboratories's Options Market Dynamics - Benzinga
IDEXX Laboratories' 15min chart: RSI Overbought, KDJ Death Cross triggered. - AInvest
Piper Sandler Adjusts Price Target on IDEXX Laboratories to $700 From $510, Maintains Neutral Rating - MarketScreener
IDEXX Laboratories: Piper Sandler Raises PT to $700 from $510 - AInvest
Idexx Laboratories Inc Insider Sold Shares Worth $5,279,893, According to a Recent SEC Filing - MarketScreener
Is Now An Opportune Moment To Examine IDEXX Laboratories, Inc. (NASDAQ:IDXX)? - 富途牛牛
IDEXX Laboratories (NASDAQ:IDXX) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat
Short Interest Drops in IDEXX Laboratories Inc. After RallyLow Capital High Return Stock Plans Reviewed - beatles.ru
IDEXX Executives Make Major Stock Trades on August 6 - AInvest
IDEXX Laboratories Inc(IDXX.US) Officer Sells US$5.28 Million in Common Stock - 富途牛牛
IDEXX Labs Volume Plummets 28% as Veterinary Diagnostics Stock Slides to 256th in U.S. Trading Activity Rankings - AInvest
IDEXX Laboratories (NASDAQ:IDXX) Price Target Raised to $675.00 at JPMorgan Chase & Co. - MarketBeat
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock - Yahoo Finance
IDEXX’s Healthy Streak Outpaces The Pack In Animal Care - Finimize
How Idexx Laboratories Is Riding The 'Puppy Boom' To New Highs - MSN
IDEXX Laboratories shares rise 3.10% intraday after Rothschild & Co Redburn raised price target to $670. - AInvest
IDEXX Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Yahoo Finance
IDEXX Laboratories, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - simplywall.st
Decoding IDEXX Laboratories Inc (IDXX): A Strategic SWOT Insight - GuruFocus
IDEXX Laboratories Q2 2025 Earnings Call: Strong Revenue and EPS Growth Amid Challenges - AInvest
BTIG Boosts Idexx Laboratories Price Target to $785 Amid Strong Q2 Earnings - AInvest
Leerink Partners Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Raises Target Price to $745 - 富途牛牛
Idexx Laboratories Inc (IDXX) 財務データ
収益
当期純利益
現金流量
EPS
Idexx Laboratories Inc (IDXX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Erickson Michael G | Executive Vice President |
Aug 12 '25 |
Sale |
649.96 |
406 |
263,813 |
11,287 |
| Hunt Nimrata | Executive Vice President |
Aug 12 '25 |
Option Exercise |
244.16 |
1,226 |
299,344 |
18,033 |
| Hunt Nimrata | Executive Vice President |
Aug 11 '25 |
Sale |
656.53 |
1,200 |
787,840 |
16,807 |
2.07%
大文字化:
|
ボリューム (24 時間):